Nyxoah to Participate in the Jefferies Global Healthcare Conference
Nyxoah to Participate in the Jefferies Global Healthcare Conference Mont-Saint-Guibert, Belgium – June 3, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical technology company
Publication Relating to Transparency Notifications
Nyxoah Completes $50M Offering And Subsequent Sale Of Additional Shares, Raising $52.5M
Nyxoah intends to use the net proceeds from the proposed offering (i) for pre-commercialization and commercialization activities in the United States; (ii) to continue gathering clinical data and to s
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces Closing of Offering and Partial Exercise ofOption to Purchase Additional Shares Mont-Saint-Guibert, Belgium – May 31, 2024, 8:00am CET / 2:00am ET – Nyxoah SA
Nyxoah SA Reveals Share Capital and Voting Rights
Information on the Total Number of Voting Rights and Shares
REGULATED INFORMATION Information on the Total Number of Voting Rights and Shares Mont-Saint-Guibert (Belgium), May 28, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the
Nyxoah SA Confirms Share Offering Agreement
H.C. Wainwright Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $18
H.C. Wainwright analyst Edward White maintains $Nyxoah SA(NYXH.US)$ with a buy rating, and adjusts the target price from $22 to $18.According to TipRanks data, the analyst has a success rate of 31.7%
Express News | Nyxoah SA : H.c. Wainwright Cuts Target Price to $18 From $22
Nyxoah Shares Drop 15% After Public Offering Launches
By Chris Wack Nyxoah shares were dropped after the company began a proposed underwritten public offering in the U.S. Shares were down 15% to $8.55 in recent trading. The stock hit its 52-week high o
Express News | Nyxoah Shares Are Trading Lower After the Company Announced the Pricing of a $50 Million Public Offering of 5,374,755 Shares at $9.25 per Share
Nyxoah Announces Pricing of Offering
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Pricing of Offering Mont-Saint-Guibert, Belgium – May 23, 2024, 3:50 pm CET / 9:50 am ET – Nyxoah SA (NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical
Oppenheimer Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $15
Oppenheimer analyst Suraj Kalia maintains $Nyxoah SA(NYXH.US)$ with a buy rating, and maintains the target price at $15.According to TipRanks data, the analyst has a success rate of 52.6% and a total
Nyxoah Announces Reduction of the Maximum Amount Available Under Its At The-Market Equity Offering Program
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Reduction of the Maximum Amount Available Under its At-the-Market Equity Offering Program Mont-Saint-Guibert, Belgium – May 22, 2024, 10:10pm CET / 4:10pm ET –
Nyxoah Announces Proposed Offering of Ordinary Shares
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium – May 22, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (NASDAQ:NYXH) ("Nyxoah" or the "Company"), a
Express News | Nyxoah Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results
Wall Street Set to Open Modestly Higher Wednesday as Inflation Dips in April
US stocks look set to open modestly higher Wednesday as key monthly inflation data came in slightly lower than expected, while annual inflation matched analyst forecasts. The Dow Jones Industrial Aver
OPEN, BCRX and AWIN Among Pre-market Gainers
Express News | Cantor Fitzgerald Maintains Overweight on Nyxoah, Lowers Price Target to $17
Express News | Nyxoah SA : Oppenheimer Cuts Target Price to $15 From $20
No Data